Adding adjuvant chemotherapy to radiotherapy did not lead to a significant survival benefit over radiotherapy alone in women ...
Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.
Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...
Trisha Wise-Draper, MD, PhD, discusses anticipated data on head and neck cancers and their potential impact on the field.
The addition of concurrent cisplatin to adjuvant radiation therapy conferred no benefit to women with intermediate-risk, ...
Negative surgical margins regardless of surgery type was associated with increased overall survival in patients with Merkel cell carcinoma.
Adjuvant CRT did not improve outcomes over adjuvant RT in patients with intermediate-risk, early-stage cervical cancer after radical hysterectomy.
Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy ...
6 which showed that global health-related quality of life at 5 years was significantly better among patients who received adjuvant radiation therapy than in those who received observation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results